Axsome Therapeutics to Present at the 22nd Annual Needham Virtual…
NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. AXSMa biopharmaceutical company that develops and offers novel therapies for the treatment of central
Home » Needham
NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. AXSMa biopharmaceutical company that develops and offers novel therapies for the treatment of central
SEATTLE, April 3, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. KAa clinical-stage biotechnology company focused on developing novel immunotherapies in oncology that address the immune resistance
XS Financial Inc.XSFXSHLFa specialty finance firm providing CAPEX and equipment finance solutions to US cannabis companies reported in its third quarter financial results announced that
Needham initiated reporting Glaucos Corp GKOS with a Price target of $66 and a purchase recommendation. The analyst writes that GKOS has lost market
Needham updated Penumbra Inc PEN Buy from hold with a price target of $244. The analyst notes that management has indicated that PEN will
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents